| Product NDC: | 0095-0950 |
| Proprietary Name: | Zolpimist |
| Non Proprietary Name: | zolpidem tartrate |
| Active Ingredient(s): | 5 mg/1 & nbsp; zolpidem tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0095-0950 |
| Labeler Name: | ECR Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022196 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101201 |
| Package NDC: | 0095-0950-05 |
| Package Description: | 1 CONTAINER in 1 CARTON (0095-0950-05) > 60 SPRAY, METERED in 1 CONTAINER |
| NDC Code | 0095-0950-05 |
| Proprietary Name | Zolpimist |
| Package Description | 1 CONTAINER in 1 CARTON (0095-0950-05) > 60 SPRAY, METERED in 1 CONTAINER |
| Product NDC | 0095-0950 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zolpidem tartrate |
| Dosage Form Name | SPRAY, METERED |
| Route Name | ORAL |
| Start Marketing Date | 20101201 |
| Marketing Category Name | NDA |
| Labeler Name | ECR Pharmaceuticals |
| Substance Name | ZOLPIDEM TARTRATE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |